Hospital admission for type 2 diabetes mellitus under the Universal Coverage Scheme in Thailand: A time- and geographical-trend analysis, 2009–2016

Abstract

Background Descriptive analyses of 2009–2016 were performed using the data of the Universal Coverage Scheme (UCS) which covers nearly 70 percent of the Thai population. The analyses described the time and geographical trends of nationwide admission rates of type 2 diabetes mellitus (T2DM) and its complications, including chronic kidney disease (CKD), myocardial infarction, cerebrovascular diseases, retinopathy, cataract, and diabetic foot amputation. Methods and findings The database of T2DM patients aged 15–100 years who were admitted between 2009 and 2016 under the UCS and that of the UCS population were retrieved for the analyses. The admitted cases of T2DM were extracted from the database using disease codes of principal and secondary diagnoses defined by the International Classification of Diseases 9th and 10th Revisions. The T2DM admission rates in 2009–2016 were the number of admissions divided by the number of the UCS population. The standardized admission rates (SARs)were further estimated in contrast to the expected number of admissions considering age and sex composition of the UCS population in each region. A linearly increased trend was found in T2DM admission rates from 2009 to 2016. Female admission rates were persistently higher than that of males. In 2016, an increase in the T2DM admission rates was observed among the older ages relative to that in 2009. Although the SARs of T2DM were generally higher in Bangkok and central regions in 2009, except that with CKD and foot amputation which had higher trends in northeastern regions, the geographical inequalities were fairly reduced by 2016. Conclusion Admission rates of T2DM and its major complications increased in Thailand from 2009 to 2016. Although the overall geographical inequalities in the SARs of T2DM were reduced in the country, further efforts are required to improve the health system and policies focusing on risk factors and regions to manage the increasing T2DM.

“Life is Bitter and Sweet”: The Lived Experience of Ethnic Minority Elders with Type 2 Diabetes Mellitus in Rural, Thailand

“…In Thailand, an estimated 6.1 million ethnic minorities comprise 9% of the total population and live mostly in Chiang Rai Province [9]. The identities of ethnic minorities are displayed in multiple ways, such as lifestyle, language, beliefs, culture, attitudes, values, and economic status.…”

The Factor of Association of Diabetes Knowledge in Diabetes Mellitus type 2 patients

“…In Thailand, according to the Thailand Diabetes Registry (TDR) study (N=8,416, and the Diabetes care-Asia (Thailand) survey (N=1,078), severe complications are prevalent in both urban and rural areas. When urban and rural areas are compared, the prevalence of nephropathy (44% vs. 17%); retinopathy (31% vs. 13.6%), cardiovascular problems (8% vs. 0.7%), and stroke (4.4% vs. 1.9%) is higher in urban areas [13][14][15]. The specific prevalence of peripheral neuropathy is not reported but is estimated to be 34% in rural areas.…”

Temporal Trends in Renal Replacement Therapy in Community-Based People with or without Type 2 Diabetes: The Fremantle Diabetes Study

“…Although there is some evidence of CKD leading to end-stage kidney disease (ESKD) and the need for renal replacement therapy (RRT) has been declining in parallel with CVD in type 2 diabetes in some countries, the trend has not been as marked as that for major CVD outcomes such as myocardial infarction (MI) and stroke [2,3]. In addition, recent national data relating to temporal trends in CKD complicating type 2 diabetes are inconsistent, with some studies showing a reduction [3,13] and others an increase [12,[14][15][16][17] in CKD hospitalizations and progression to RRT. The use of administrative data in these studies has well-recognized limitations, including incomplete ascertainment of diabetes and its type, misclassification of endpoints, inconsistent follow-up and missing patient-level data, and lack of detailed data relating to risk factors and clinical management.…”